Table 2.
Type D personality stability at 208 weeks of follow-up.
| tDp Stable (n = 19) | tDp Loss (n = 21) | p-value | |
|---|---|---|---|
| Age (years) | 52.78 ± 2.5 | 51.8 ± 2.38 | 0.78 |
| Male: female ratio | 9:10 | 12:9 | 0.53 |
| BMI | 28.22 ± 1.62 | 28.75 ± 1.54 | 0.81 |
| Educational level primary incomplete vs. secondary-academic | 6 (31.58) vs. 13 (68.42) | 1 (4.76) vs. 20 (95.24) | 0.03 |
| Marital status single-married vs. divorced-windowed | 14 (73.68) vs. 5 (26.32) | 21 (100.00) vs. 0 (0.00) | 0.02 |
| PASI (baseline) | 5.14 ± 1.08 | 3.88 ± 1.02 | 0.40 |
| PASI (week 208) | 3.67 ± 0.79 | 1.47 ± 0.76 | 0.05 |
| HADS-A >8 (%) | 13 (68.42) | 12 (57.14) | 0.46 |
| HADS-D >8 (%) | 11 (57.89) | 8 (38.10) | 0.20 |
| Baseline psoriasis treatment (%) | 0.29 | ||
| Topical | 3 (15.79) | 4 (19.05) | |
| Classical systemic drugs | 9 (47.37) | 5 (23.81) | |
| Biological drugs | 7 (36.84) | 12 (57.14) | |
| Final psoriasis treatment (%) | 0.39 | ||
| Topical | 1 (5.26) | 4 (19.05) | |
| Classical systemic drugs | 2 (10.53) | 2 (9.52) | |
| Biological drugs | 16 (84.21) | 15 (71.43) |
TDp, type D personality consists of a tendency to inhibit the expression of emotions or behavior to avoid negative reactions from others (social inhibition: SI), in combination with the stable tendency to experience negative affectivity (NA). Data are expressed as mean ± standard deviation and as number (percentage); BMI, Body Mass Index; PASI, Psoriasis Area and Severity Index; HADS, the Hospital Anxiety and Depression Scale-Anxiety (HADS-A) and Depression (HADS-D); p-values refer to the comparison of patients in whom type D personality remains stable and in those who lose it.